T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Trump Media & Technology Group
DJT
$2.32B
| $1.77M | ﹤0.01% |
133,635
+31,988
| +31% | +$436K |
|
1802
S&T Bancorp
STBA
$1.81B
| $1.76M | ﹤0.01% |
44,795
+3,212
| +8% | +$124K |
|
1803
Crescent Energy
CRGY
$4B
| $1.75M | ﹤0.01% |
209,136
+60,492
| +41% | +$531K |
|
1804
Howard Hughes
HHH
$4.01B
| $1.75M | ﹤0.01% |
21,954
+319
| +1% | +$26.4K |
|
1805
Olin
OLN
$2.19B
| $1.75M | ﹤0.01% |
83,987
+4,153
| +5% | +$89.6K |
|
1806
TriNet
TNET
$3.18B
| $1.75M | ﹤0.01% |
29,586
-209,324
| -88% | -$12.4M |
|
1807
TriCo Bancshares
TCBK
$1.86B
| $1.74M | ﹤0.01% |
36,812
+1,039
| +3% | +$47.7K |
|
1808
MannKind Corp
MNKD
$1.2B
| $1.74M | ﹤0.01% |
307,158
+39,218
| +15% | +$216K |
|
1809
Vishay Intertechnology
VSH
$5.25B
| $1.73M | ﹤0.01% |
119,017
+4,886
| +4% | +$74.1K |
|
1810
Donnelley Financial Solutions
DFIN
$1.22B
| $1.72M | ﹤0.01% |
36,829
-356,851
| -91% | -$17.3M |
|
1811
Greif
GEF
$4.98B
| $1.72M | ﹤0.01% |
25,319
+1,088
| +4% | +$68.1K |
|
1812
Gibraltar Industries
ROCK
$1.44B
| $1.71M | ﹤0.01% |
34,623
+1,922
| +6% | +$110K |
|
1813
OneSpaWorld
OSW
$2.74B
| $1.71M | ﹤0.01% |
82,418
+9,948
| +14% | +$208K |
|
1814
The RealReal
REAL
$1.33B
| $1.7M | ﹤0.01% |
107,975
+2,308
| +2% | +$30.1K |
|
1815
Atlanta Braves Holdings Series B
BATRK
$3.4B
| $1.7M | ﹤0.01% |
43,063
+7,387
| +21% | +$292K |
|
1816
Recursion Pharmaceuticals
RXRX
$1.71B
| $1.7M | ﹤0.01% |
415,363
+96,479
| +30% | +$478K |
|
1817
ArcBest
ARCB
$3.28B
| $1.7M | ﹤0.01% |
22,883
+1,954
| +9% | +$139K |
|
1818
Federal Agricultural Mortgage
AGM
$2.52B
| $1.7M | ﹤0.01% |
9,663
+723
| +8% | +$122K |
|
1819
iShares MSCI Canada ETF
EWC
$6.57B
| $1.7M | ﹤0.01% |
31,451
| – | – |
|
1820
Allegiant Air
ALGT
$2.35B
| $1.69M | ﹤0.01% |
19,862
+106
| +0.5% | +$7.58K |
|
1821
EyePoint Inc
EYPT
$1.17B
| $1.69M | ﹤0.01% |
92,570
+10,658
| +13% | +$151K |
|
1822
Hillman Solutions
HLMN
$1.7B
| $1.69M | ﹤0.01% |
195,348
+23,431
| +14% | +$211K |
|
|
HTO
1823
H2O America
HTO
$2.65B
| $1.69M | ﹤0.01% |
34,484
+3,364
| +11% | +$161K |
|
1824
C3.ai
AI
$1.57B
| $1.69M | ﹤0.01% |
125,230
+18,096
| +17% | +$289K |
|
1825
Global Net Lease
GNL
$1.91B
| $1.68M | ﹤0.01% |
195,376
+15,573
| +9% | +$125K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.